These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33122893)

  • 1. Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells.
    Shen Y; TanTai J
    Drug Des Devel Ther; 2020; 14():4503-4510. PubMed ID: 33122893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synergistic approach for management of lung carcinoma through folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: Enhanced apoptosis and metalloproteinase-9 down-regulation.
    Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Kaithwas G; Saraf SA
    Phytomedicine; 2019 Feb; 53():107-123. PubMed ID: 30668390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
    Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
    Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Experiments (DoE) Approach to Optimize the Sustained Release Microparticles of Gefitinib.
    Soni G; Yadav KS; Gupta MK
    Curr Drug Deliv; 2019; 16(4):364-374. PubMed ID: 30588883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
    Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
    Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.
    Jain S; Spandana G; Agrawal AK; Kushwah V; Thanki K
    Mol Pharm; 2015 Nov; 12(11):3871-84. PubMed ID: 26375023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Mitoxantrone-Loaded Quercetin Nanoparticles for Breast Cancer Therapy with Potential for Synergism with Bioactive Natural Products.
    Alkhaldi O; Abusulieh S; Abusara OH; Sunoqrot S
    Int J Pharm; 2024 Nov; 665():124674. PubMed ID: 39245083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
    Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
    Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells.
    Faramarzi L; Dadashpour M; Sadeghzadeh H; Mahdavi M; Zarghami N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):737-746. PubMed ID: 30892093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization.
    Chary PS; Bansode A; Rajana N; Bhavana V; Singothu S; Sharma A; Guru SK; Bhandari V; Mehra NK
    Int J Pharm; 2024 May; 657():124109. PubMed ID: 38626846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of multifunctional PEG-graft-Halloysite Nanotubes for Controlled Drug Release, Tumor Cell Targeting, and Bio-imaging.
    Yamina AM; Fizir M; Itatahine A; He H; Dramou P
    Colloids Surf B Biointerfaces; 2018 Oct; 170():322-329. PubMed ID: 29936385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.